Terns Pharmaceuticals

We are pleased to announce the appointment of Heather Turner, J.D., to our Board of Directors. With 25 years of strategic, operational, and legal expertise, Heather brings invaluable leadership to Terns as we continue to grow and innovate.? ? Heather’s extensive experience in #obesity and #oncology, combined with her deep understanding of all stages of therapeutic product development, will play a key role in advancing our portfolio of innovative #smallmolecule therapies targeting serious diseases, including chronic myeloid #leukemia and #obesity.? ? Welcome, Heather! For details: https://lnkd.in/ew9DwdRG

Attending the Jefferies Global Healthcare Conference 2024 in London this week? Join us today at 5 p.m. GMT for a #firesidechat featuring Amy Burroughs and Emil Kuriakose, MD, where we’ll share updates on our clinical development programs designed to address serious diseases, including #obesity and #oncology.?? ? A live webcast and #replay will be available on our website at https://ir.ternspharma.com. #JefferiesHealthcare??

Our Clinical and Medical Affairs teams had a fantastic time in San Antonio, connecting with professionals committed to advancing #obesity research and care at #ObesityWeek2024. Inspired by insightful discussions on innovative therapies, including our work with next-gen small molecule GLP-1 receptor agonists, we're more energized than ever to tackle the global challenge of obesity. A big thank you to the speakers and participants who made this event a success. Together, we're moving the needle toward transformative change in obesity care. ObesityWeek?

Our management team will participate in a #firesidechat today at 8:45 a.m. PT during the UBS Global Healthcare Conference in Rancho Palos Verdes, CA, where we'll share updates on our development programs focused on serious diseases including #oncology and #obesity. If you can’t join, a live webcast and #replay will be available on our website at https://ir.ternspharma.com.

Today we reported our financial results and provided business updates for the third quarter of 2024.? ? See our press release for details: https://lnkd.in/ebyGzRBx

#ICYMI we recently shared positive top-line results from our Phase 1 clinical trial of an investigational oral #GLP-1R agonist in healthy adults with #obesity or overweight.? These findings represent important progress in our ongoing efforts to explore innovative treatments for obesity. We are encouraged by the potential of our approach and remain focused on advancing therapies that could positively impact the lives of those affected by obesity. Check out this article from Citeline Scrip for more insights: https://lnkd.in/e7e_nWMB or read our press release for details https://lnkd.in/e6VXMJ5U

We’re participating in a panel discussion today at 3:25 p.m. ET during the Truist Securities Biopharma Symposium in NYC focused on the latest developments in #obesity and metabolic health, including our research programs.?? ? #TruistBiopharmaSymposium??

Live from #ObesityWeek2024 – where our team is diving into the latest obesity research and connecting with industry professionals. We’re gaining actionable insights from each presentation and discussion, strengthening our commitment to advancing support for individuals with #obesity.?? ? We’re looking forward to interacting with other attendees to explore how we can collaborate to advance patient outcomes in the #metabolic field! ObesityWeek?

Our Chief Business Officer Melita Sun Jung is looking forward to connecting with fellow professionals and exploring partnership opportunities at #BIOEurope next week, November 4-6, in Stockholm. This event brings together leaders from the global #lifescience community to discuss the latest advancements and share insights on innovative approaches to healthcare.? ? At Terns, we are committed to advancing groundbreaking therapies for serious diseases, including #oncology and #obesity, and we believe that collaboration is key to driving progress in the field. If you’re attending, let us know—we’d love to hear from you and discuss how we can collaborate to advance lifescience innovations together!

In the spirit of Halloween, our team came together for a festive company luncheon and costume contest. It was a fun opportunity to celebrate creativity and team bonding with everyone showing up in unique costumes that brought plenty of laughs. From spooky to silly, the variety was fantastic.?? ? A big thank you to everyone who participated and brought the fun – our judges certainly had a tough job picking the winners!